Answers are grounded in this paper and cite their sources.
The use of synthetic peptides representing cytotoxic T-cell (CTL) epitopes for human vaccination requires the identification of a suitable adjuvant formulation. A single immunization with Montanide ISA720/tetanus toxoid/YPHFMPTNL protected mice against murine cytomegalovirus and induced epitope-specific CTL. Such formulations will find application in peptide-based CTL anti-viral vaccines.
No takes yet. Share an insight, caveat, or question.
Scalzo et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: